Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
Myriad Genetics’ third quarter saw revenue and adjusted profit in line with Wall Street expectations, but the market reacted negatively due to ongoing challenges in average revenue per test and ...
Human Geneticist Dr. Neville Sanjana answers the internet’s burning questions about genetics and DNA. How are our genes related to our DNA? Does our DNA change during our lifetime? How do services ...
Increasing acceptance that evolution can be ‘rapid’ (or ‘contemporary’) has generated growing interest in the consequences for ecology. The genetics and genomics of these ‘eco-evolutionary dynamics’ ...
Recently, Myriad Genetics, Inc.’s MYGN myChoice CDx test has been added under the American Society of Clinical Oncology’s (“ASCO”) latest recommendations on the use of PARP inhibitors for treatment ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results